Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Author(s) -
Tom T. Shimabukuro,
Shin Y. Kim,
Tanya R. Myers,
Pedro L. Moro,
Titilope Oduyebo,
Lakshmi Panagiotakopoulos,
Paige Marquez,
Christine K. Olson,
Ruiling Liu,
Karen Chang,
Sascha Ellington,
Veronica Burkel,
Ashley N. Smoots,
Caitlin J. Green,
Charles Licata,
Bicheng C. Zhang,
Meghna Alimchandani,
Adamma MbaJonas,
Stacey W. Martin,
Julianne Gee,
Dana MeaneyDelman
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2104983
Subject(s) - pregnancy , medicine , vaccination , adverse effect , chills , obstetrics , abortion , myalgia , gestation , gestational age , pediatrics , adverse event reporting system , pandemic , disease , covid-19 , immunology , infectious disease (medical specialty) , genetics , biology
Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in pregnancy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom